HORIBA Medical and CellaVision collaborate on new automated Digital Cell Morphology solution to enhance lab workflows

HORIBA UK Ltd, Medical has introduced a new automated digital cell morphology solution in collaboration with CellaVision to help hematology laboratories simplify and expedite the performance of blood and body fluid differentials.

Image Credit: HORIBA Medical

CellaVision’s digital cell morphology systems can now be integrated with HORIBA’s HELO automated haematology platform, enabling unique two-way data flow and rapid validation of cell morphology results.

These combined systems automate a number of steps that would otherwise be undertaken manually, thus significantly enhancing laboratory workflows and increasing productivity.

The connectivity and bi-directional information sharing between CellaVision and HORIBA’s hematology systems uniquely support numerous aspects of digital blood cell morphology workflow. These save technician and cytologist time, support ease-of-use, improve flexibility, and deliver more accurate results.

CellaVision systems leverage high-speed robotics and digital imaging to automatically locate and capture high-quality images of cells from slides produced by HORIBA’s Yumizen SPS slide maker following automatic slide reflex rules.

By automating pre-classification and pre-characterization of blood cell morphology, this slide digitalization solution saves time and supports the standardization of slide reading when compared to the use of a traditional microscope for validation of blood smears. In turn, all results and alarms from HORIBA’s hematology analyzers can be directly sent to CellaVision.

Data received from HORIBA hematology analyzers are used by CellaVision systems in a number of ways to enhance workflows. As all slides are printed with 1D or 2D barcodes by the SPS, automatic distinction of whole blood and body fluids slides are possible without the need for specific color-coded racks when loading.

Furthermore, based on the HORIBA analyzer’s WBC value, the CellaVision system will automatically adjust the number of pictures it captures to ensure sufficient and representative cell counting. This offers convenience in cases of leucopenia or aplasia.

Further supporting ease-of-use and saving personnel time, automatic access to the HORIBA analyzer’s values, alarms, and comments on the CellaVision interface facilitates slide review on a single interface during validation.

Also offering convenience in the decision-making process, all comments made on CellaVision are automatically integrated into HORIBA’s Yumizen P8000 middleware and expert validation station. Furthermore, the analyzer result can be confirmed on the CellaVision which the P800 will then automatically validate and send to the LIS, so improving turnaround time.

Mandy Campbell, Sales and Marketing Manager - Medical, HORIBA UK Ltd, commented, “Slide reading is a mandatory step in laboratories to confirm severe pathology diagnosis.

By automating and digitizing cell morphology workflow our new joint solution with CellaVision offers significant time saving and results in standardization to enable laboratories to work smarter and perform better.”

A range of CellaVision systems is available to integrate with HORIBA’s HELO hematology platform which can be selected based on a laboratory’s size and throughput.

The CellaVision® DM9600 meets the needs of large laboratories with high-volume testing requirements, offering a loading capacity of 96 slides and a throughput of 30 slides/hour. For large or small laboratories with lower volume testing needs, the CellaVision® DM1200 and CellaVision® DC-1 offer alternative options.

For more information on HORIBA UK Ltd. Medical and its products, please visit www.horiba.com/uk/medical.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    HORIBA Medical. (2024, June 24). HORIBA Medical and CellaVision collaborate on new automated Digital Cell Morphology solution to enhance lab workflows. News-Medical. Retrieved on November 23, 2024 from https://www.news-medical.net/news/20200430/HORIBA-Medical-and-CellaVision-collaborate-on-new-automated-Digital-Cell-Morphology-solution-to-enhance-lab-workflows.aspx.

  • MLA

    HORIBA Medical. "HORIBA Medical and CellaVision collaborate on new automated Digital Cell Morphology solution to enhance lab workflows". News-Medical. 23 November 2024. <https://www.news-medical.net/news/20200430/HORIBA-Medical-and-CellaVision-collaborate-on-new-automated-Digital-Cell-Morphology-solution-to-enhance-lab-workflows.aspx>.

  • Chicago

    HORIBA Medical. "HORIBA Medical and CellaVision collaborate on new automated Digital Cell Morphology solution to enhance lab workflows". News-Medical. https://www.news-medical.net/news/20200430/HORIBA-Medical-and-CellaVision-collaborate-on-new-automated-Digital-Cell-Morphology-solution-to-enhance-lab-workflows.aspx. (accessed November 23, 2024).

  • Harvard

    HORIBA Medical. 2024. HORIBA Medical and CellaVision collaborate on new automated Digital Cell Morphology solution to enhance lab workflows. News-Medical, viewed 23 November 2024, https://www.news-medical.net/news/20200430/HORIBA-Medical-and-CellaVision-collaborate-on-new-automated-Digital-Cell-Morphology-solution-to-enhance-lab-workflows.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
HORIBA Medical’s Yumizen G200 hemostasis device validated for use with UK NEQAS BC samples